Insider transaction details
On March 25, 2026, Jessica Flores, who serves as Executive Vice President and Chief Accounting Officer of Sabra Health Care REIT (NASDAQ: SBRA), sold 15,231 shares of the company's common stock. The shares were transacted at a weighted average price of $19.86 per share for a total consideration of $302,487. Reported sale prices for the lot fell between $19.85 and $19.89.
Holdings after the sale
After completing the disposition, Flores is reported to directly own 71,709 shares of Sabra Health Care REIT. That total includes 25,527 stock units that will be settled on a one-for-one basis into shares of the issuer's common stock.
Quarterly financials
In an accompanying update, Sabra Health Care REIT reported its fourth-quarter 2025 results. The company reported earnings per share of $0.11, falling short of the consensus forecast of $0.17. The reported EPS therefore represented a 35.29% negative surprise relative to the estimate. Revenue for the quarter amounted to $211.9 million, above the forecasted $196.95 million and representing a 7.59% positive surprise versus expectations.
Analyst action and specific balance-sheet note
Truist Securities adjusted its price target on Sabra to $22 from $21 and maintained a Hold rating. In its commentary, Truist highlighted a $300 million loan receivable that is set to mature this year and stated that it expects the loan will be either extended or re-invested on similar terms.
Context and limits of the record
The share sale, the post-transaction holdings, the reported quarterly results, and the analyst action are the facts disclosed in company and market reporting. The information above reflects the data provided in those disclosures, including the precise share counts, price ranges, aggregate proceeds, reported EPS and revenue figures, and the analyst note regarding the loan receivable.